The upregulation of alternative co-inhibitory immune checkpoints on T cells is another mechanism of ICI resistance in NSCLC, including T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) and Lymphocyte Activating 3 (LAG-3) [54]. The gene discussed is HAVCR2; the disease is non-small cell lung carcinoma.